Avant Diagnostics Inc. | Income Statement
Fiscal year is October-September. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
-
-
-
-
118.00
Cost of Goods Sold (COGS) incl. D&A
-
-
-
-
392.60
Gross Income
-
-
-
-
274.50
SG&A Expense
592.10
315.50
34.30
702.00
11,284.20
EBIT
592.10
315.50
34.30
702.00
11,558.80
Unusual Expense
-
-
-
2,641.10
86.00
Non Operating Income/Expense
1,423.40
-
-
-
-
Interest Expense
-
-
-
-
114.30
Pretax Income
2,014.90
315.50
34.30
3,343.10
11,759.00
Consolidated Net Income
2,014.90
315.50
34.30
3,343.10
11,759.00
Net Income
2,014.90
315.50
34.30
3,343.10
11,759.00
Net Income After Extraordinaries
2,014.90
315.50
34.30
3,343.10
11,759.00
Net Income Available to Common
2,014.90
315.50
34.30
3,343.10
11,759.00
EPS (Basic)
0.32
0.05
0.01
0.04
0.08
Basic Shares Outstanding
6,206.90
6,301.90
6,317.00
85,839.00
146,223.70
EPS (Diluted)
0.32
0.05
0.01
0.04
0.08
Diluted Shares Outstanding
6,206.90
6,301.90
6,317.00
85,839.00
146,223.70
EBITDA
592.10
315.50
34.30
702.00
11,218.70
Non-Operating Interest Income
0.60
-
-
-
-
About Avant Diagnostics
View Profile
